Cargando…
Identification of a novel DNA aptamer that selectively targets lung cancer serum
Lung cancer is the leading cause of cancer-related deaths worldwide. Early diagnosis and treatment is critical to improving the 5 year survival rate of lung cancer. The identification of new options for early-stage diagnosis and therapy of lung cancer still represents a crucial challenge. Therefore,...
Autores principales: | Zhao, Yunwang, He, Lei, Huang, Baihai, Zhang, Weidong, Hu, Ailing, Li, Baolin, Liao, Shiqi, Wang, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042271/ https://www.ncbi.nlm.nih.gov/pubmed/35497520 http://dx.doi.org/10.1039/d1ra06233f |
Ejemplares similares
-
DNA aptamers from whole-serum SELEX as new diagnostic agents against gastric cancer
por: Zheng, Yue, et al.
Publicado: (2019) -
In vitro selection of DNA aptamers for the development of chemiluminescence aptasensor for neuron-specific enolase (NSE) detection
por: Zheng, Yue, et al.
Publicado: (2019) -
Selection and preliminary application of a single stranded DNA aptamer targeting colorectal cancer serum
por: Li, Kun, et al.
Publicado: (2019) -
Selection of aptamers for AMACR detection from DNA libraries with different primers
por: Yang, Deng-Kai, et al.
Publicado: (2018) -
Rapid selection of aptamers based on protein microarray
por: Yu, Fang, et al.
Publicado: (2019)